Perinatal Journal, cilt.33, sa.1, ss.1-4, 2025 (Scopus)
Objective: Although postnatal hepatitis B vaccine and hepatitis B immunoglobulin are administered to infants of hepatitis B carrier mothers, it is recommended that the infants’ hepatitis B immunization be evaluated 3-6 months after vaccination. Our aim is to evaluate the immunization levels of infants born to hepatitis B carrier mothers and whose vaccination has been completed. Methods: In this observational study, the hepatitis B serologies of term infants born to hepatitis B carrier mothers, who were vaccinated and immunoglobulin-treated and vaccinated, and who were followed up in our outpatient clinic between 2015-2017 were evaluated. Results: A total of 19 babies born to hepatitis B carrier mothers, whose immunization was completed, who came to our clinic for follow-up, with an average gestational age of 39.1 ± 1.2 weeks and a birth weight of 3465 ± 566 grams, were evaluated at an average age of 19.7 ± 7.8 months. 68.4% of the babies (13 babies) were born by cesarean section. The average duration of breastfeeding was 6 ± 3.1 months. Anti-HBs was not observed in 2 of the babies (10.5%). Hepatitis B vaccination was repeated in the cases. Conclusion: All babies born to hepatitis B carrier mothers, even if they are healthy term babies with completed vaccination, should definitely be evaluated and monitored in terms of immunization, and breastfeeding should not be stopped.